Cargando…
Energetic dissection of Gleevec’s selectivity towards human tyrosine kinases
Protein kinases are obvious drug targets against cancer due to their central role in cellular regulation. Since the discovery of Gleevec, a potent and specific inhibitor of Abl kinase, as a highly successful cancer therapeutic, the ability of this drug to distinguish between Abl and other tyrosine k...
Autores principales: | Agafonov, R.V., Wilson, C., Otten, R., Buosi, V., Kern, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266587/ https://www.ncbi.nlm.nih.gov/pubmed/25218445 http://dx.doi.org/10.1038/nsmb.2891 |
Ejemplares similares
-
Dynamics of human protein kinase Aurora A linked to drug selectivity
por: Pitsawong, Warintra, et al.
Publicado: (2018) -
Computational
Study of Gleevec and G6G Reveals Molecular
Determinants of Kinase Inhibitor Selectivity
por: Lin, Yen-Lin, et al.
Publicado: (2014) -
Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003) -
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008) -
Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells
por: Pan, Jingxuan
Publicado: (2012)